Story · Medicine & Biotech

AstraZeneca Acquires Omniose to Strengthen Vaccine Development Against Serious Bacterial Infections

1 outlet · first reported by Medical Dialogues 15h ago

Coverage, in order

  1. 15h ago
    Medical Dialogues India obscure
    AstraZeneca Acquires Omniose to Strengthen Vaccine Development Against Serious Bacterial Infections

    Bengaluru : AstraZeneca has acquired Omniose, an early-stage biotechnology firm developing vaccines ‌against serious bacterial infections, and folded the ‌business into its infectious diseases division, the target company said ​on Tuesday. Financial terms of the deal were not disclosed The…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.